Advanced In Vivo Imaging To Understand Cancer Systems (NCI) (R01) (RFA-CA-11-005)
Letter of intent due date: January 23, 2011
Application due date: February 23, 2011
The purpose of this Funding Opportunity Announcement (FOA) is to provide an opportunity for new collaborative projects among in vivo cancer imaging scientists, cancer complexity researchers and other experts that focus on the integration of advanced in vivo imaging technologies with systems biology approaches to understand complex cancer phenomena at highest resolution. This FOA will support collaborative research projects focused on bridging state of the art cancer imaging and cancer complexity research. The proposed projects include the development of new in vivo imaging technologies or the adaptation of existing technologies if they are specifically focused on the elucidation of complex cancer phenomena at high resolution. They may include the development of new informatics methods or computational approaches that incorporate cancer imaging data into computational models of complex cancer processes.
Shared Instrumentation Grant Program (NCRR) (S10) (Par-11-081)
Application due date: March 23, 2011
The NCRR Shared Instrument Grant (SIG) program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instrumentation or an integrated system that costs at least $100,000. The maximum award is $600,000.
Cancer Prevention Research Small Grant Program (NCI) (R03) (Par-11-079)
Application due dates: March 18, 2011; July 21, 2011; December 16, 2011; February 15, 2012; July 18, 2012; December 14, 2012; February 15, 2013; July 19, 2013; December 16, 2013
The National Cancer Institute (NCI) invites applications that propose small and time-limited projects pertinent to the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, and/or clinical prevention studies that focus on specific target organs. Proposed projects may involve basic animal and/or translational research and/or human subjects-oriented research. Specific areas of research may include biomarkers of molecular and genetic cancer risk factors; imaging technology.
Translating Basic Behavioral And Social Science Discoveries Into Interventions To Improve Health-Related Behaviors (Multiple ICs, Including NCI) (R01) (PA-11-063)
This FOA seeks highly innovative Research Project Grant (R01) applications that propose to translate findings from basic research on human behavior into effective clinical, community, or population-based behavioral interventions to improve health. Specifically, this FOA will support interdisciplinary teams of basic and applied biological, behavioral and/or social science researchers in developing and refining novel behavioral interventions with high potential impact to improve health-promoting behaviors. The following is intended only as conceptual examples: Use research findings from neuroimaging studies to map the neural mechanisms underlying the targeted behaviors to develop novel approaches to change behaviors.
Institutional Clinical And Translational Science Award (U54) (RFA-RM-10-020) (NOT-RM-11-006 For Correction)
Letter of intent due date: May 11, 2011
Application due date: Renewal applications: June 11, 2011; new applications: October 3, 2011
This FOA invites applications for Clinical and Translational Science Award (CTSA) from new applicants and from current awardees. The CTSA program sustains and advances clinical and translational science as a distinct discipline. NIH resources give institutions flexibility to develop their existing configuration, resources and talent to maximize the safety, efficiency, quality and speed of clinical and translational research. Resources that could be requested include advanced technologies such as mass spectrometry, imaging, ultrasound, positron emission tomography, gene expression, proteomics, translational cell and gene therapies and technologies for patient monitoring or examination.
URL for Notice of Correction: http://grants.nih.gov/grants/guide/notice-files/NOT-RM-11-006.html
Translational Tools For Clinical Studies Of Mind/Body And Manual Therapy CAM Interventions (R01) (NCCAM)(RFA-AT-11-003)
Letter of intent due date: March 29, 2011
Application due date: April 29,2011
This Funding Opportunity Announcement (FOA) issued by the National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH) encourages investigator(s)-initiated applications that propose to develop, enhance, and validate translational tools to facilitate rigorous study of complementary/alternative medicine (CAM) approaches that are in wide use by the public. Examples of translations tools research topics include development of neuroimaging markers to assess measures of brain and central nervous system mechanisms and pathways.
Translational Research Centers In Thrombotic And Hemostatic Disorders (TRC-THD) (U54) (RFA-HL-12-008)
Letter of intent due date: March 1, 2011
Application due date: April 1, 2011
The National Heart, Lung, and Blood Institute (NHLBI) solicits grant applications to participate in the Translational Research Centers in Thrombotic and Hemostatic Disorders (TRC-THD). The primary objective of this new Centers program is to enhance the translation of basic research discoveries that could lead to improved prevention, diagnosis, and treatment for thrombotic and hemostatic disorders. The TRC-THD will advance early stage translation research, integrating applied and basic science to move research discoveries toward clinical application. Examples of possible topics for research include biomarkers or imaging methods to assess bleeding and thrombotic tendency, to monitor response to therapy, or to monitor thrombosis progression and resolution.
Functional Genetics, Epigenetics, And Non-Coding RNAs In Drug Addiction (NIDA) (R01: PA-11-033) (R21: PA-11-034) (R03: PA-11-035)
Application due date: standard dates apply
This Funding Opportunity Announcement encourages basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. Studies to identify in vivo human or animal gene/variant/epigenetic effects on neuronal activity or brain functions relevant to addiction are appropriate. These may include specific behaviors associated with addictive processes which may be genetically based and that are influenced by neurocircuitry or neuroconnectivity that may be assessed by a variety of imaging techniques such as fMRI, DTI, MRS, or PET.
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PA-11-033.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PA-11-034.html
URL for R03: http://grants.nih.gov/grants/guide/pa-files/PA-11-035.html
Understanding And Treating Co-Morbid Conditions In Adolescents With Intellectual And Developmental Disabilities (R01) (NICHD) (R01: PA-11-039) (R21: PA-11-041) (R03: PA-11-040)
Application due date: standard dates apply
The objective is to create a more substantial base of evidence to inform future research directions in studies of adolescents with intellectual and developmental disabilities and to better meet the medical, psychosocial, and psychiatric needs of a growing population of individuals with IDD in the United States and internationally. Some illustrative examples of research topics include comparative studies to address plasticity in specific brain circuits during adolescence, including the use of novel and functional imaging techniques, in IDD and/or typically developing populations.
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PA-11-039.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PA-11-041.html
URL for R03: http://grants.nih.gov/grants/guide/pa-files/PA-11-040.html
Indo-US Collaborative Program On Low-Cost Medical Devices (R03)(NIAID, NIBIB, NICHD)(PAR-11-044)
Letters of Intent Receipt Date(s): December 26, 2010
Application Due Date(s): January 26, 2011, May 24, 2011, September 23, 2011, January 24, 2012, May 24, 2012, September 24, 2012, January 24, 2013, May 24, 2013, September 24, 2013
The purpose of this program is to encourage collaborative research and/or technology development between scientists and engineers in the United States and India for the program on the collaborative development of new low-cost diagnostic and therapeutic medical devices. Appropriate medical technologies are those that are useable, cost effective, sustainable, and effective in meeting a significant clinical need in a low-resource setting. Collaborations should be aimed at the development, translation and use of medical technologies that can significantly impact underserved populations within the United States and/or India. The scope includes low-cost imaging for tertiary care hospitals, mobile or portable imaging devices, and low-cost C-arm, ultrasound, and CT.
Women And Sex/Gender Differences In Drug And Alcohol Abuse/Dependence (NIDA, NIAAA) (R01: PA-11-047) (R21: PA-11-048) (R03: PA-11-049)
Application due date: standard dates apply
The purpose of this Funding Opportunity Announcement is to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. Areas of research interest include, but are not limited to examination of sex/gender differences in the use of biobehavioral assays (e.g., brain-imaging technology, stress reactivity, HPA indices) in predicting treatment outcomes.
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PA-11-047.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PA-11-048.html
URL for R03: http://grants.nih.gov/grants/guide/pa-files/PA-11-049.html
Studies In Neonatal Hypoglycemia (NICHD) (R01: PA-11-053) (R21: PA-11-055) (R03: PA-11-054)
Letters of Intent Receipt Date(s): 30 days prior to the application due date
Application Due Date(s): Standard dates apply
This funding opportunity announcement is to encourage Research Project Grant (R01) applications from institutions and organizations to propose studies related to basic, applied and translational research in neonatal hypoglycemia. Among the specific areas of interest are mentioned determining the relationship between plasma concentrations of energy substrates on brain structure and function, with such techniques as imaging, mass spectroscopy and 1H, 31P nuclear magnetic resonance spectroscopy, and longitudinal phenotypic evaluations in genetically-modified animal models and in human beings to establish cause-and-effect paradigms; determining the role for neuroimaging to assess simultaneous changes in brain structure and function with plasma glucose and alternate fuel concentrations; establishing the role of serial Magnetic Resonance Imaging (MRI) with diffusion weighted cuts and high-resolution imaging in different layers of cortex in infants with hypoglycemia to assess the specificity of reported MR spectroscopy lesions to hypoglycemia; establishing longitudinal trends in MRI results in symptomatic cases of hypoglycemia; and developing outcome prediction paradigms on the basis of neuroimaging.
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PA-11-053.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PA-11-055.html
URL for R03: http://grants.nih.gov/grants/guide/pa-files/PA-11-054.html
NIH Summer Research Experience Programs (Multiple ICs, Not NCI) (R25) (PAR-11-050)
Application due dates: February 1, 2011; August 1, 2011; August 1, 2012
The purpose of the NIH Summer Research Experience Program (referred to as the "Summer Research Program") is to provide a high quality research experience for high school and college students and for science teachers during the summer academic break. Support for science teachers at the K-12 and college level will be limited to those programs with a clear plan for how the teachers will utilize their summer experience in their teaching during the school year.
Focal Cognitive Deficits In CNS Disorders (NINR, NICHD, OBSSR) (R01: PA-11-067) (R21: PA-11-069) (R03: PA-11-068)
Application due dates: standard dates apply
The purpose of this Funding Opportunity Announcement is to invite grant applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders. Examples of projects that would be appropriate include utilizing emerging technologies and imaging to predict, treat and measure focal cognitive deficits over time and develop new or utilize existing technology to measure an intervention's functional impact on the individual in the community; examples of such technologies include but are not limited to personal digital assistants (PDAs), the Internet, global positioning systems (GPS), and telephone, and biological impact technologies such as functional neuroimaging.
URL for R01: http://grants.nih.gov/grants/guide/pa-files/PA-11-067.html
URL for R21: http://grants.nih.gov/grants/guide/pa-files/PA-11-069.html
URL for R03: http://grants.nih.gov/grants/guide/pa-files/PA-11-068.html
Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral Fellowships in Muscular Dystrophy Research (NIAMS) (F32) (PA-11-075)
Application due dates: standard dates apply
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) individual Postdoctoral fellowship (F32) program is to provide support to promising applicants with the potential to become productive and successful independent research investigators in scientific health-related fields relevant to the programmatic interests of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). NIAMS is interested in supporting additional training fellowship opportunities in muscular dystrophy research. Among the general examples of appropriate research is developing improved outcome measures and non-invasive methods such as enhanced imaging or analysis of muscle function to monitor changes due to treatment or disease progression.
Mentored Patient-Oriented Research Career Development Award in Muscular Dystrophy Research (NIAMS, NICHD) (K23: PA-11-076)
Mentored Clinical Scientist Research Career Development Award in Muscular Dystrophy Research (K08: PA-11-077)
NIH Pathway to Independence Award in Muscular Dystrophy Research (K99/R00: PA-11-078)
Application due dates: standard dates apply
NICHD joins the above effort (PA-11-075) in supporting additional career development and mentoring opportunities in muscular dystrophy research. See discussion above.
URL for K23: http://grants.nih.gov/grants/guide/pa-files/PA-11-076.html
URL for K08: http://grants.nih.gov/grants/guide/pa-files/PA-11-077.html
URL for K99/R00: http://grants.nih.gov/grants/guide/pa-files/PA-11-078.html
Collaborative Research in Computational Neuroscience (CRCNS) Innovative Approaches to Science and Engineering Research on Brain Function (NSF, multiple NIH ICs, German Federal Ministry of Education and Research) [R01] (NOT-NS-11-006)
Application due dates: February 16, 2011, November 2, 2011 and November 2, 2012
Through the CRCNS program, participating NSF DOs, NIH ICs and BMBF support innovative interdisciplinary collaborative research to make significant advances in the understanding of structures and functions of the nervous system, mechanisms underlying nervous system disorders, and computational strategies used by the nervous system. The participating agencies recognize the need for research that focuses on integrating computational models and methods with neuroscience. Please see the notice and NSF announcement for details.
Other Funding Agencies
American Association of Physicists in Medicine and RSNA Medical Physics Funding Opportunities
Consult the AAPM URLs below for specific details.
2011 Summer Undergraduate Fellowship Program, including description of mentorship
2011 Minority Undergraduate Summer Experience (MUSE) Program
The RSNA and the AAPM 2011 Fellowship for Graduate Study in Medical Physics
2011 RSNA Support for Full-Time Clinical Residencies in Diagnostic Medical Physics
2011 - 2013 AAPM Support for Clinical Residency in Imaging Medical Physics
2011 Research Seed Funding Initiative
Reminder: Policies Affecting Submission of NIH Grant Applications for Due Dates on or after January 25, 2011 (NOT-OD-11-021)
URL for correction: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-023.html
Look at this NIAID web site for sample R01 grants in the new format.
CIP DCIDE PROGRAM MORPHS INTO NExT
The Cancer Imaging Program's DCIDE program for providing data to investigators for their IND filings is being absorbed by the NCI Experimental Therapeutics Program (NExT). Submissions are due quarterly, on the 15th of February, May, August and November.
GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE
The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at firstname.lastname@example.org. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
RSNA Clinical Trials Methodology Workshop
January 15-21, 2011, Scottsdale, AZ
Multimodality Molecular Imaging of Prostate Cancer
Friday, January 21, 2011, Palm Springs, California
Part of the SNM 2011 Mid-Winter Meetings
SPIE Photonics West Conference
January 22 - 27, 2011, The Moscone Center, San Francisco, CA
RSNA Writing a Competitive Grant Proposal Workshop
February 11-12, 2011, RSNA Headquarters, Oak Park, IL
Register by January 5, 2011
SPIE Medical Imaging Conference
February 12 - 17, 2011, Lake Buena Vista (Orlando), FL
ISMRM Workshop on Ultra High Field Systems & Applications: 7T & Beyond: Progress, Pitfalls & Potential, Lake Louise, Alberta, Canada - 21-23 February 2011
Breast Cancer Imaging: State of the Art 2011: Diagnosis, Therapy and Beyond
April 21-22, 2011, Bethesda, Maryland
The Natcher Center, National Institutes of Health
2011 NIH Regional Seminars on Program Funding and Grants Administration: Phoenix, AZ & Ft. Lauderdale, FL (NOT-OD-10-129)
April 27-29, 2011 - Phoenix, AZ: (Registration expected to open early November 2010).
June 22-24, 2011 - Ft. Lauderdale, FL: (Registration expected to open early 2011).
19th ISMRM Scientific Annual Meeting & Exhibition
Montreal, Quebec, Canada - 7-13 May 2011
2011 International Symposium on Ultrasonic Imaging and Tissue Characterization
June 13 - 15, 2011, Palomar Hotel, Arlington, VA
Frontiers of Biomedical Imaging Science III
June 13 - 16, 2011, Vanderbilt University, Nashville, TN
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (email@example.com).
Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI
6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531Fax: 301 480 3507